Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigemitsu Yasuda

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 10, 2006
[Molecular biology in regulation of kidney functions: Calcitonin]Seiki Wada, Shigemitsu Yasuda
Clinical Calcium|August 3, 2006
[Diabetic osteopahty and vitamin K]Shigemitsu Yasuda, Seiki Wada
Internal Medicine (Tokyo, Japan)|August 2, 2021
Neurofibromatosis Type 1 with Concurrent Multiple Endocrine Disorders: Adenomatous Goiter, Primary Hyperparathyroidism, and AcromegalyShigemitsu Yasuda, Ikuo Inoue, Akira Shimada
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 18, 2003
[Glucocorticoid-induced osteoporosis]Shigemitsu Yasuda, Masakazu Kogawa, Seiki Wada
Journal of Clinical Medicine Research|August 28, 2020
Examination of Malignant Findings of Thyroid Nodules Using Thyroid UltrasonographyDaigo Saito, Ritsuko Nakajima, Shigemitsu Yasuda
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 11, 2005
[Calcitonin actions on kidney]Shigemitsu Yasuda, Katsuhiro Ono, Seiki Wada
Endocrinology|January 13, 2004
Interaction between 3' untranslated region of calcitonin receptor messenger ribonucleic acid (RNA) and adenylate/uridylate (AU)-rich element binding proteins (AU-rich RNA-binding factor 1 and Hu antigen R)Shigemitsu Yasuda, Seiki Wada, Yukitomo Arao, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 21, 2013
Tumor-induced osteomalacia: benign tumor recurrence after two surgical resections at two different medical institutionsShigemitsu Yasuda, Seiki Wada, Shinjiro Kono, et al.
Clinical Endocrinology|October 2, 2002
A case of primary mucoepidermoid carcinoma of the thyroid: molecular evidence of its originAkinobu Minagawa, Makoto Iitaka, Miho Suzuki, et al.
Molecular Endocrinology (Baltimore, Md.)|June 12, 2004
Stability of A+U-rich element binding factor 1 (AUF1)-binding messenger ribonucleic acid correlates with the subcellular relocalization of AUF1 in the rat uterus upon estrogen treatmentYukitomo Arao, Atsumi Kikuchi, Mitsuyo Kishida, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 10, 2006
[Molecular biology in regulation of kidney functions: Calcitonin]Seiki Wada, Shigemitsu Yasuda
Clinical Calcium|August 3, 2006
[Diabetic osteopahty and vitamin K]Shigemitsu Yasuda, Seiki Wada
Internal Medicine (Tokyo, Japan)|August 2, 2021
Neurofibromatosis Type 1 with Concurrent Multiple Endocrine Disorders: Adenomatous Goiter, Primary Hyperparathyroidism, and AcromegalyShigemitsu Yasuda, Ikuo Inoue, Akira Shimada
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 18, 2003
[Glucocorticoid-induced osteoporosis]Shigemitsu Yasuda, Masakazu Kogawa, Seiki Wada
Journal of Clinical Medicine Research|August 28, 2020
Examination of Malignant Findings of Thyroid Nodules Using Thyroid UltrasonographyDaigo Saito, Ritsuko Nakajima, Shigemitsu Yasuda
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 11, 2005
[Calcitonin actions on kidney]Shigemitsu Yasuda, Katsuhiro Ono, Seiki Wada
Endocrinology|January 13, 2004
Interaction between 3' untranslated region of calcitonin receptor messenger ribonucleic acid (RNA) and adenylate/uridylate (AU)-rich element binding proteins (AU-rich RNA-binding factor 1 and Hu antigen R)Shigemitsu Yasuda, Seiki Wada, Yukitomo Arao, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 21, 2013
Tumor-induced osteomalacia: benign tumor recurrence after two surgical resections at two different medical institutionsShigemitsu Yasuda, Seiki Wada, Shinjiro Kono, et al.
Clinical Endocrinology|October 2, 2002
A case of primary mucoepidermoid carcinoma of the thyroid: molecular evidence of its originAkinobu Minagawa, Makoto Iitaka, Miho Suzuki, et al.
Molecular Endocrinology (Baltimore, Md.)|June 12, 2004
Stability of A+U-rich element binding factor 1 (AUF1)-binding messenger ribonucleic acid correlates with the subcellular relocalization of AUF1 in the rat uterus upon estrogen treatmentYukitomo Arao, Atsumi Kikuchi, Mitsuyo Kishida, et al.
Pageof 2